Natalie J. Serkova

Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G₁ Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2

Jennifer L. Spratlin, Roger B. Cohen, Matthew Eadens et al. · Journal of Clinical Oncology · 2010 · 551 citations · Full text

MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer

Surendra K. Shukla, Vinee Purohit, Kamiya Mehla et al. · Cancer Cell · 2017 · 531 citations · Full text

Tumor Biology, Impart Gemcitabine Resistance, Pancreatic Cancer +7

Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions

Thomas J. Anchordoquy, Yechezkel Barenholz, Diana Boraschi et al. · ACS Nano · 2017 · 321 citations

Nanoparticles, Engineering, Biomedical Engineering +17

Imatinib (STI571)-Mediated Changes in Glucose Metabolism in Human Leukemia BCR-ABL-Positive Cells

Sven Gottschalk, Nora Anderson, Carsten Hainz et al. · Clinical Cancer Research · 2004 · 258 citations · Full text

Hematological Malignancy, Systems Biology, Glucose Metabolism +15

Metabolic regulation in the lactating mammary gland: a lipid synthesizing machine

Michael C. Rudolph, James L. McManaman, Tzulip Phang et al. · Physiological Genomics · 2006 · 252 citations

Mammary Gland Development, Human Lactation, Biosynthesis +17